SE467861B - Emulsion foer parenteral administrering - Google Patents

Emulsion foer parenteral administrering

Info

Publication number
SE467861B
SE467861B SE8705064A SE8705064A SE467861B SE 467861 B SE467861 B SE 467861B SE 8705064 A SE8705064 A SE 8705064A SE 8705064 A SE8705064 A SE 8705064A SE 467861 B SE467861 B SE 467861B
Authority
SE
Sweden
Prior art keywords
emulsion
agents
emulsion according
alkyl esters
esters
Prior art date
Application number
SE8705064A
Other languages
English (en)
Swedish (sv)
Other versions
SE8705064D0 (sv
SE8705064L (sv
Inventor
K A J Wretlind
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20370646&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE467861(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE8705064A priority Critical patent/SE467861B/sv
Publication of SE8705064D0 publication Critical patent/SE8705064D0/xx
Priority to US07/771,862 priority patent/US5244925A/en
Priority to CA000585715A priority patent/CA1334281C/en
Priority to EP88850423A priority patent/EP0321429A1/en
Priority to AT89900673T priority patent/ATE95695T1/de
Priority to AU28214/89A priority patent/AU624107B2/en
Priority to JP1500461A priority patent/JP2930242B2/ja
Priority to AU28214/89A priority patent/AU2821489A/en
Priority to EP89900673A priority patent/EP0353267B1/en
Priority to PCT/SE1988/000680 priority patent/WO1989005638A1/en
Priority to ES89900673T priority patent/ES2059827T3/es
Priority to DE89900673T priority patent/DE3884945T2/de
Publication of SE8705064L publication Critical patent/SE8705064L/
Priority to FI893867A priority patent/FI99080C/fi
Priority to NO893303A priority patent/NO176745C/no
Priority to DK198904052A priority patent/DK173596B1/da
Publication of SE467861B publication Critical patent/SE467861B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8705064A 1987-12-18 1987-12-18 Emulsion foer parenteral administrering SE467861B (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE8705064A SE467861B (sv) 1987-12-18 1987-12-18 Emulsion foer parenteral administrering
US07/771,862 US5244925A (en) 1987-12-18 1988-12-01 Emulsion for parenteral administration
CA000585715A CA1334281C (en) 1987-12-18 1988-12-13 Emulsion for parenteral administration
ES89900673T ES2059827T3 (es) 1987-12-18 1988-12-14 Emulsion para administracion parenteral.
AT89900673T ATE95695T1 (de) 1987-12-18 1988-12-14 Emulsion fuer parenterale verabreichung.
AU28214/89A AU2821489A (en) 1987-12-18 1988-12-14 Emulsion for parenteral administration
DE89900673T DE3884945T2 (de) 1987-12-18 1988-12-14 Emulsion für parenterale verabreichung.
AU28214/89A AU624107B2 (en) 1987-12-18 1988-12-14 Emulsion for parenteral administration
JP1500461A JP2930242B2 (ja) 1987-12-18 1988-12-14 非経口投与用エマルジヨン
EP88850423A EP0321429A1 (en) 1987-12-18 1988-12-14 Emulsion for parenteral administration
EP89900673A EP0353267B1 (en) 1987-12-18 1988-12-14 Emulsion for parenteral administration
PCT/SE1988/000680 WO1989005638A1 (en) 1987-12-18 1988-12-14 Emulsion for parenteral administration
FI893867A FI99080C (fi) 1987-12-18 1989-08-16 Menetelmä ruoansulatuskanavan ulkopuoliseen annosteluun tarkoitettujen emulsioiden valmistamiseksi
DK198904052A DK173596B1 (da) 1987-12-18 1989-08-17 Emulsion til parenteral indgivelse
NO893303A NO176745C (no) 1987-12-18 1989-08-17 Fremgangsmåte for fremstilling av en emulsjon inneholdende alkylestere av fettsyrer for parenteral administrering

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8705064A SE467861B (sv) 1987-12-18 1987-12-18 Emulsion foer parenteral administrering

Publications (3)

Publication Number Publication Date
SE8705064D0 SE8705064D0 (sv) 1987-12-18
SE8705064L SE8705064L (sv) 1989-06-19
SE467861B true SE467861B (sv) 1992-09-28

Family

ID=20370646

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8705064A SE467861B (sv) 1987-12-18 1987-12-18 Emulsion foer parenteral administrering

Country Status (11)

Country Link
EP (2) EP0321429A1 (fi)
JP (1) JP2930242B2 (fi)
AU (1) AU2821489A (fi)
CA (1) CA1334281C (fi)
DE (1) DE3884945T2 (fi)
DK (1) DK173596B1 (fi)
ES (1) ES2059827T3 (fi)
FI (1) FI99080C (fi)
NO (1) NO176745C (fi)
SE (1) SE467861B (fi)
WO (1) WO1989005638A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69130531T2 (de) * 1990-07-19 1999-04-22 Unicliffe Ltd., Stonar, Kent Diagnostisches mittel zur bestimmung von pankreasinsuffiziens
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
US8324366B2 (en) 2008-04-29 2012-12-04 Alnylam Pharmaceuticals, Inc. Compositions and methods for delivering RNAI using lipoproteins
AU2010221419B2 (en) 2009-03-02 2015-10-01 Alnylam Pharmaceuticals, Inc. Nucleic acid chemical modifications
WO2011123621A2 (en) 2010-04-01 2011-10-06 Alnylam Pharmaceuticals Inc. 2' and 5' modified monomers and oligonucleotides
US20130260460A1 (en) 2010-04-22 2013-10-03 Isis Pharmaceuticals Inc Conformationally restricted dinucleotide monomers and oligonucleotides
US9725479B2 (en) 2010-04-22 2017-08-08 Ionis Pharmaceuticals, Inc. 5′-end derivatives
US10913767B2 (en) 2010-04-22 2021-02-09 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising acyclic and abasic nucleosides and analogs
WO2012096697A1 (en) * 2011-01-14 2012-07-19 Simpkins Cuthbert O Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
PT3597644T (pt) 2011-10-18 2021-11-03 Dicerna Pharmaceuticals Inc Lípidos catiónicos de amina e suas utilizações

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3158541A (en) * 1959-12-18 1964-11-24 Escambia Chem Corp Product for reduction of blood cholesterol concentration
BE637252A (fi) * 1961-09-25
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
FR2553661B1 (fr) * 1983-10-19 1985-12-20 Rhone Poulenc Sante Nouvelles microemulsions pharmaceutiquement acceptables
EP0145873B1 (en) * 1983-12-16 1989-01-04 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Transfusion emulsion

Also Published As

Publication number Publication date
EP0353267A1 (en) 1990-02-07
AU2821489A (en) 1989-07-19
JP2930242B2 (ja) 1999-08-03
NO893303D0 (no) 1989-08-17
DK173596B1 (da) 2001-04-23
DE3884945D1 (de) 1993-11-18
DE3884945T2 (de) 1994-02-10
FI893867A0 (fi) 1989-08-16
CA1334281C (en) 1995-02-07
JPH02502540A (ja) 1990-08-16
NO176745C (no) 1995-05-24
EP0353267B1 (en) 1993-10-13
NO176745B (no) 1995-02-13
DK405289D0 (da) 1989-08-17
EP0321429A1 (en) 1989-06-21
DK405289A (da) 1989-08-17
SE8705064D0 (sv) 1987-12-18
ES2059827T3 (es) 1994-11-16
SE8705064L (sv) 1989-06-19
FI99080B (fi) 1997-06-30
NO893303L (no) 1989-08-17
FI99080C (fi) 1997-10-10
WO1989005638A1 (en) 1989-06-29

Similar Documents

Publication Publication Date Title
US5244925A (en) Emulsion for parenteral administration
DE69232564T2 (de) Phospholipide
DE2601207C3 (de) Verfahren zur Herstellung einer flüssigen pharmazeutischen Zubereitung mit gesteuertem Arzneimittelabgabevermögen
PL186354B1 (pl) Jałowe kompozycje farmaceutyczne oraz sposoby ograniczania potencjału wzrostowego drobnoustrojów i poprawiania czasu stosowania emulsji
EP1488785A1 (de) Ölemulsion zur postnatalen Hormonsubstitution
EP0581842B1 (en) An organ specific emulsion
FI98047C (fi) Röntgenvarjoaineena käytettävä jodipitoinen emulsio
SE467861B (sv) Emulsion foer parenteral administrering
AU574438B2 (en) Method for directed visceral metabolism of medium chain triglycerides
CN1093283A (zh) 用于降低毒性并增强药效的组合物和方法
DE60011625T2 (de) Cisplatin enthaltende parenterale emulsion
JP2019210222A (ja) 水中油型乳化組成物及びその製造方法
DE69902925T2 (de) Ramoplaninhaltige neue injizierbare arzneizubereitungen
JPS60166626A (ja) 血管造影剤
EP1526838B1 (de) Intraven s applizierbare, pharmazeutische darreichungsform
EP0313617B1 (en) Lipid emulsion and method for intravenous infusion
AU624107B2 (en) Emulsion for parenteral administration
JPH0565220A (ja) 輸液製剤
JPH05301825A (ja) 輸液製剤

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8705064-7

Format of ref document f/p: F

NUG Patent has lapsed